Danese, Silvio
IRCCS Ospedale San Raffaele
20 papers on CoChatORCID 0000-0001-7341-1351
Most cited papers
- Verified
STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD
Turner, D., Ricciuto, A., Lewis, A., D’Amico, F., Dhaliwal, J., Griffiths, A. M., Bettenworth, D., Sandborn, W. J., Sands, B. E., Reinisch, W., et al. (2021) · Gastroenterology
Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome
Cited by 2,911
- Verified
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
Gadaleta, R. M., van Erpecum, K. J., Oldenburg, B., Willemsen, E. C. L., Renooij, W., Murzilli, S., Klomp, L. W. J., Siersema, P. D., Schipper, M. E. I., Danese, S., et al. (2011) · Gut
Inflammatory Bowel DiseaseGut microbiota and health
Cited by 870
- Verified
Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study
Tursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G. M., Forti, G., Morini, S., Hassan, C., Pistoia, M. A., et al. (2010) · American Journal of Gastroenterology
Inflammatory Bowel DiseaseProbiotics and Fermented Foods
Cited by 489
- Verified
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study
Sands, B. E., Chen, J., Feagan, B. G., Penney, M., Rees, W. A., Danese, S., Higgins, P. D. R., Newbold, P., Faggioni, R., Patra, K., et al. (2017) · Gastroenterology
Inflammatory Bowel DiseasePsoriasis: Treatment and Pathogenesis
Cited by 279
- Verified
Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)
Danese, S., Vermeire, S., Hellstern, P., Panaccione, R., Rogler, G., Fraser, G., Kohn, A., Desreumaux, P., Leong, R. W., Comer, G. M., et al. (2019) · Gut
Inflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies
Cited by 181
- Verified
Breaking through the therapeutic ceiling: what will it take?
Raine, T., & Danese, S. (2022) · Gastroenterology
Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome
Cited by 160
- Verified
Big data in IBD: a look into the future
Olivera, P., Danese, S., Jay, N., Natoli, G., & Peyrin-Biroulet, L. (2019) · Nature Reviews Gastroenterology & Hepatology
Inflammatory Bowel DiseaseBig Data Technologies and Applications
Cited by 151
- Verified
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease
Lopetuso, L. R., Deleu, S., Godny, L., Petito, V., Puca, P., Facciotti, F., Sokol, H., Ianiro, G., Masucci, L., Abreu, M., et al. (2023) · Gut
Inflammatory Bowel DiseaseGut microbiota and health
Cited by 129
- Verified
Artificial intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis
Iacucci, M., Parigi, T. L., Del Amor, R., Meseguer, P., Mandelli, G., Bozzola, A., Bazarova, A., Bhandari, P., Bisschops, R., Danese, S., et al. (2023) · Gastroenterology
Inflammatory Bowel DiseaseAI in cancer detection
Cited by 127
- Verified · note
Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Bonovas, S., Fiorino, G., Allocca, M., Lytras, T., Tsantes, A., Peyrin-Biroulet, L., & Danese, S. (2016) · Medicine
Iron Metabolism and DisordersInflammatory Bowel Disease
Cited by 113
- Verified
Milan ultrasound criteria are accurate in assessing disease activity in ulcerative colitis: external validation
Allocca, M., Filippi, E., Costantino, A., Bonovas, S., Fiorino, G., Furfaro, F., Peyrin‐Biroulet, L., Fraquelli, M., Caprioli, F., & Danese, S. (2021) · United European Gastroenterology Journal
Inflammatory Bowel DiseaseMicroscopic Colitis
Cited by 107
- Verified
Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule
Ben Nasr, M., Usuelli, V., Dellepiane, S., Seelam, A. J., Fiorentino, T. V., D’Addio, F., Fiorina, E., Xu, C., Xie, Y., Balasubramanian, H. B., et al. (2024) · Cell Metabolism
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 102
- Verified
ECCO position on harmonisation of Crohn's disease mucosal histopathology
Magro, F., Sabino, J., Rosini, F., Tripathi, M., Borralho, P., Baldin, P., Danese, S., Driessen, A., Gordon, I. O., Iacucci, M., et al. (2022) · Journal of Crohn's and Colitis
Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome
Cited by 76
- Verified
Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease
Iacucci, M., Santacroce, G., Zammarchi, I., Maeda, Y., Del Amor, R., Meseguer, P., Kolawole, B. B., Chaudhari, U., Di Sabatino, A., Danese, S., et al. (2024) · The Lancet Gastroenterology & Hepatology
Inflammatory Bowel DiseaseArtificial Intelligence in Healthcare and Education
Cited by 73
- Verified
Challenges and opportunities in IBD clinical trial design
Dubinsky, M. C., Collins, R., Abreu, M. T., Abreu, M. T., Collins, R., Dubinsky, M. C., Jairath, V., Lewis, J. D., Lindsay, J., Merad, M., et al. (2021) · Gastroenterology
Inflammatory Bowel DiseaseStatistical Methods in Clinical Trials
Cited by 34
- Verified
Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta‐analysis
Magro, F., Moreira, P. L., Catalano, G., Alves, C., Roseira, J., Estevinho, M. M., Silva, I., Dignass, A., Peyrin‐Biroulet, L., Danese, S., et al. (2023) · United European Gastroenterology Journal
Inflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies
Cited by 30
- Verified
Long-term safety of approved biologics for ulcerative colitis
D’Amico, F., Parigi, T. L., Bonovas, S., Peyrin-Biroulet, L., & Danese, S. (2020) · Expert Opinion on Drug Safety
Inflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies
Cited by 29
- Verified
Chronic inflammatory diseases: do immunological patterns drive the choice of biotechnology drugs? A critical review
Sozzani, S., Abbracchio, M. P., Annese, V., Danese, S., De Pità, O., De Sarro, G., Maione, S., Olivieri, I., Parodi, A., & Sarzi-Puttini, P. (2014) · Autoimmunity
Biosimilars and Bioanalytical MethodsRheumatoid Arthritis Research and Therapies
Cited by 22
- Verified
Safety of vedolizumab in liver transplant recipients: a systematic review
Spadaccini, M., Aghemo, A., Caprioli, F., Lleo, A., Invernizzi, F., Danese, S., & Donato, M. F. (2019) · United European Gastroenterology Journal
Inflammatory Bowel DiseaseRenal Transplantation Outcomes and Treatments
Cited by 20
- Verified
The Role of Filgotinib in Ulcerative Colitis and Crohn’s Disease
Fanizza, J., D’Amico, F., Lauri, G., Martinez-Dominguez, S. J., Allocca, M., Furfaro, F., Zilli, A., Fiorino, G., Parigi, T. L., Radice, S., et al. (2024) · Immunotherapy
Inflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies
Cited by 16
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free